Clinical studies

The Department of Pulmonary Medicine at Karolinska University Hospital in Stockholm conducted a qualitative study of FlexO2 over a six month period, in collaboration with Karolinska Institute and the Swedish Research Council. The study evaluated FlexO2 both from a patient, relative and staff perspective regarding user friendliness and function. 18 participants took part in the study, which took the following structure:

Participants completed an initial questionnaire
They then used FlexO2 for a three-month period, completing a questionnaire at the end of that time
For the next three months, participants stopped using FlexO2, completing one final questionnaire at the end of the study period

When moving into the phase where the FlexO2 device was due to be taken away, almost half of the patients chose to leave the study to be able to keep using FlexO2.

The study is now completed, and the final report will be published shortly. Whilst waiting for this report we are pleased to show some initial feedback that has been shared with us.

Without FlexO2 most study subjects had trouble changing the oxygen dosage.

FlexO2 facilitated individual adjustments of oxygen.

The ability to have an active life was estimated to be lower without FlexO2

FlexO2 increased the possibility for an active life in the home.

When moving into the phase where the FlexO2 device would be taken away, almost half of the patients chose to leave the study to be able to keep using FlexO2.

The best thing that has happened to me in the last twenty years
A study participant